From January 24, 2024 to March 31, 2024, the company has repurchased 1,646,320 shares, representing 0.48% for CNY 27.78 million. With this, the company has completed the repurchase of 1,646,320 shares, representing 0.48% for CNY 27.78 million under the buyback announced on January 24, 2024.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.29 CNY | +0.47% | -1.73% | -11.15% |
05-31 | Zhejiang Tianyu Pharmaceutical Co., Ltd. Announces Dividend Implementation for 2023, Payable on 06 June 2024 | CI |
05-06 | China Approves Tianyu Pharma's Heart Medication | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.15% | 916M | |
+18.09% | 41.07B | |
+24.16% | 22.65B | |
+20.11% | 14.14B | |
+52.15% | 12.09B | |
-0.05% | 6.79B | |
-10.97% | 6.91B | |
-8.87% | 5.73B | |
+15.28% | 5.59B | |
+4.00% | 4.82B |
- Stock Market
- Equities
- 300702 Stock
- News Zhejiang Tianyu Pharmaceutical Co., Ltd.
- Tranche Update on Zhejiang Tianyu Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 24, 2024.